Arpita Roy, PhD
Affiliations: | 2015-2019 | Urologic Oncology Branch | National Cancer Institue-NIH |
| 2020- | U.S. Food and Drug Administration (FDA), San Diego, CA, United States |
Google:
"Arpita Roy"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald P Bottaro | post-doc | 2015-2019 | U.S. Food and Drug Administration (FDA) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Karthic A, Roy A, Lakkakula J, et al. (2022) Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review. Frontiers in Cell and Developmental Biology. 10: 984311 |
| Velhal K, Barage S, Roy A, et al. (2022) A Promising Review on Cyclodextrin Conjugated Paclitaxel Nanoparticles for Cancer Treatment. Polymers. 14 |
| Lee YH, Lee MM, De Silva DM, et al. (2021) Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. Plos One. 16: e0241766 |
| Roy A. (2020) Plumbagin: A potential anti-cancer compound. Mini Reviews in Medicinal Chemistry |
| Apolo AB, Nadal R, Tomita Y, et al. (2020) Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. The Lancet. Oncology |
| Maimouni S, Lee MH, Sung YM, et al. (2019) Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival. Oncotarget. 10: 1606-1624 |
| Roy A, Ramalinga M, Kim OJ, et al. (2017) Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition. Plos One. 12: e0180344 |
| De Silva DM, Roy A, Kato T, et al. (2017) Targeting the hepatocyte growth factor/Met pathway in cancer. Biochemical Society Transactions |
| Matsumoto K, Umitsu M, De Silva DM, et al. (2017) HGF-MET in cancer progression and biomarker discovery. Cancer Science |
| Roy A, DeSilva DM, Bottaro DP. (2017) Abstract 5530: Evidence linking aquaporin-3 loss to increased invasiveness in bladder cancer Cancer Research. 77: 5530-5530 |